
Update on the epidemiology of carbapenemases in Latin America and the Caribbean
2020; Taylor & Francis; Volume: 19; Issue: 2 Linguagem: Inglês
10.1080/14787210.2020.1813023
ISSN1744-8336
AutoresJuan Carlos García-Betancur, Tobías Manuel Appel, Germán Esparza, Ana Cristina Gales, Gabriel Levy-Hara, Wanda Cornistein, Silvio Vega, Duilio Núñez, Luis E. Cuéllar, Luis Bavestrello, Paulo Castañeda-Méndez, Juan Villalobos-Vindas, María Virginia Villegas,
Tópico(s)Antibiotic Use and Resistance
ResumoCarbapenemases are β-lactamases able to hydrolyze a wide range of β-lactam antibiotics, including carbapenems. Carbapenemase production in Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp., with and without the co-expression of other β-lactamases is a serious public health threat. Carbapenemases belong to three main classes according to the Ambler classification: class A, class B, and class D.Carbapenemase-bearing pathogens are endemic in Latin America. In this review, we update the status of carbapenemases in Latin America and the Caribbean.Understanding the current epidemiology of carbapenemases in Latin America and the Caribbean is of critical importance to improve infection control policies limiting the dissemination of multi-drug-resistant pathogens and in implementing appropriate antimicrobial therapy.
Referência(s)